Boston Scientific announces agreement to acquire Penumbra, Inc.
1 day ago · Boston Scientific announces agreement to acquire Penumbra, Inc. Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence …
Boston Scientific to acquire Penumbra for $14.5B
1 day ago · Image courtesy of Penumbra. “Penumbra is a well-established company with an experienced, high-performing team and this acquisition offers Boston Scientific an opportunity …
Boston Scientific is buying Penumbra for $14.5 billion, gaining …
15 hours ago · Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to …
Boston Scientific beefs up heart device portfolio with $14.5...Boston …
16 hours ago · Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, as it looks to re-enter the neurovascular market …
Boston Scientific signs US$14.5 billion Penumbra deal
15 hours ago · Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about US$14.5 billion to expand its portfolio of cardiovascular devices. Medtech …
The Thrombectomy Titan: Boston Scientific Shakes MedTech with …
12 hours ago · The Boston Scientific-Penumbra merger is a defining moment for the medical device industry in 2026. It marks the transition of mechanical thrombectomy from a specialized …
Boston Scientific to Buy Penumbra in $14.5 Billion DealBoston ...
16 hours ago · Jan 15 (Reuters) - Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 billion to expand its portfolio of cardiovascular …
Boston Scientific beefs up heart device portfolio with Penumbra …
15 hours ago · Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 billion to expand its portfolio of cardiovascular devices.
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
16 hours ago · Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Boston Scientific announces agreement to acquire Penumbra, Inc.
16 hours ago · "Penumbra is a well-established company with an experienced, high-performing team and this acquisition offers Boston Scientific an opportunity to enter new, fast-growing …